Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis

Journal of Rheumatology

Volumn 23, Issue 12, 1996, Pages 2152-2155

  Oliveri, M Beatriz ^a,d   Palermo, Rosa ^b   Mautalen, Carlos ^c   Hübscher, Osvaldo ^b  

^a Institute of Composite and Biomedical Materials   (Italy)

^b HMISI   (Argentina)

^c Hospital de Clínicas   (Argentina)

^d NONE   (Argentina)

Author keywords

calcinosis; dermatomyositis; diltiazem

Indexed keywords

CALCIUM; DILTIAZEM; METHOTREXATE; METHYLPREDNISOLONE; PAMIDRONIC ACID; VITAMIN D;

ARTICLE; CALCINOSIS; CASE REPORT; DERMATOMYOSITIS; DISEASE COURSE; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PHOTON ABSORPTIOMETRY; PRIORITY JOURNAL; SCHOOL CHILD; SKELETON RADIOGRAPHY;

EID: 0030472708     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bowyer SL, Blane CE, Sullivan DB, Cassidy JT: Childhood dermatomyositis: Factors predicting functional outcome and development of dystrophic calcification. J Pediatr 1983;103:882-8.
2. Sewell JR, Liyanage B, Ansell BM: Calcinosis in juvenile dermatomyositis. Skeletal Radiol 1978;3:137-43.
3. Del Río L, Carrascosa A, Pons F, Gusinyé M, Yeste D, Domenech FM: Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescent changes related to age, sex and puberty. Pediatr Res 1994;35:362-6.
4. Reid I, Schooler B, Stewart A: Prevention of glucocorticoid induced osteoporosis. J Bone Miner Res, 1990;5:619-23.
5. Struys A, Snelder AA, Mulder H: Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. Am J Med 1995;99:235-42.
6. Bonjour JP, Theintz G, Buchs B, Slosman D, Rizzoli R: Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991;73:555-63.
7. Farah MJ, Palmieri GMA, Sebes JI, Cremer MA, Massie JD, Pinals RS: The effect of dilliazem on calcinosis in a patient with the CREST syndrome. Arthritis Rheum 1990;33:1287-93.
8. Dolan AL, Kassimos D, Gibson T, Kingsley GH: Diltiazem induces remission of calcinosis in scleroderma. Br J Rheumatol 1995;34:576-8.
9. Palmieri GMA, Sebes JI, Aelion JA, et al. Treatment of calcinosis with diltiazem. Arthritis Rheum 1995;38:1646-54.
10. Malleson P: Controversies in juvenile dermatomyositis. J Rheumatol 1990;(suppl 23)17:1-6.
11. Dubowitz V: Treatment of dermatomyositis in childhood. Arch Dis Child 1976;51:494-6.
12. Cram RL, Barmada R, Geho WB, Ray RD: Diphosphonate treatment of calcinosis universalis. N Engl J Med 1971;285:1012-3.
13. Metzger AL, Singer F, Bluestone R, Pearson CM: Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma. N Engl J Med 1974;291:1294-6.
14. Wilsher ML, Holdaway JM, North JDK: Hypercalcemia during resolution of calcinosis in juvenile dermatomyositis. BMJ 1984;288:1345.
15. Ostrov BE, Goldsmith DP, Eichenfield AH, Athreya BH: Hypercalcemia during the resolution of calcinosis universalis in juvenile dermatomyositis. J Rheumatol 1991;18:1730-2.
16. Steiner RM, Glassman L, Schwartz MW, Vanace P: The radiological findings in dermatomyositis of childhood. Radiology 1974;111:385-93.
17. Martinez Cordero E, Lopez-Zepeda J, Choza-Romero F: Calcinosis in childhood dermatomyositis (letter). Clin Exp Rheumatol 1990;8:198-200.
18. Berger RG, Featherstone GL, Raasch RH, McCartney WH, Hadler NM: Treatment of calcinosis universalis with low-dose warfarin. Am J Med 1987;83:72-6.
19. Aihara J, Mori M, Ibe M, et al: A case of juvenile dermatomyositis with calcinosis universalis. Remarkable improvement with aluminum hydroxide therapy. Ryumachi 1994;34:879-84.
20. Dent CE, Stamp TCB: Treatment of calcinosis circumscripta with probenecid. BMJ 1972;1:216-8.